Stocktoria
Savara Inc SVRA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2001-06-25
Savara Inc insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Lowrance David L | Chief Financial Officer | 2026-06-22 | Tax withheld | 21,682 | $5.50 |
| Lowrance David L | Chief Financial Officer | 2026-06-22 | Option exercise | 129,350 | $1.23 |
| Lowrance David L | Chief Financial Officer | 2026-06-22 | Tax withheld | 28,928 | $5.50 |
| Lowrance David L | Chief Financial Officer | 2026-06-22 | Option exercise | 56,937 | $1.11 |
| Lowrance David L | Chief Financial Officer | 2026-06-22 | Tax withheld | 11,491 | $5.50 |
| Lowrance David L | Chief Financial Officer | 2026-06-22 | Option exercise | 218,750 | $1.51 |
| Lowrance David L | Chief Financial Officer | 2026-06-22 | Tax withheld | 60,057 | $5.50 |
| Lowrance David L | Chief Financial Officer | 2026-06-22 | Option exercise | 75,000 | $1.59 |
Source: SEC EDGAR filings · CIK 0001160308 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.